Markos Kaminis
Long/short equity, special situations, growth at reasonable price, deep value

BioTelemetry Selected As Small-Cap Growth Pick

CardioNet (NASDAQ:BEAT), just renamed BioTelemetry, soared by 38% on a day a couple weeks ago, taking this tiny company to a market capitalization of approximately $192 million by the close of trading. The huge gain came on extraordinary volume of 8.99 million shares traded, versus the 3-month average of 730K. Obviously, there was a catalyst, and it was the best possible of all drivers that moved the shares. CardioNet reported its second quarter earnings after the close of trading the day before, and I think it's safe to say the news was well received. We take a closer look at the results and the company herein. After seven years of following small-cap stocks as a senior analyst on...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details